Insulin Patch Pumps

Global Insulin Patch Pumps Market to Reach US$2.7 Billion by 2030

The global market for Insulin Patch Pumps estimated at US$1.4 Billion in the year 2023, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Basal & Bolus Delivery Mode, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Basal Delivery Mode segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$362.3 Million While China is Forecast to Grow at 13.0% CAGR

The Insulin Patch Pumps market in the U.S. is estimated at US$362.3 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$610.2 Million by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Insulin Patch Pumps Market - Key Trends and Drivers Summarized

Why Are Insulin Patch Pumps Transforming Diabetes Management?

Insulin patch pumps are revolutionizing diabetes management by offering a convenient, discreet, and efficient way to deliver insulin to patients with diabetes. Unlike traditional insulin pumps, which involve tubing and infusion sets, patch pumps are small, wearable devices that adhere directly to the skin and deliver insulin via a tiny cannula. These pumps allow patients to maintain better glucose control with fewer injections and improved flexibility in their daily routines. Insulin patch pumps are particularly popular among individuals with type 1 diabetes, who require continuous insulin administration. The integration of smart technology, such as continuous glucose monitoring (CGM) systems, is further enhancing the accuracy and ease of insulin delivery, making patch pumps a game-changer in diabetes care.

How Are Technological Advancements Shaping the Insulin Patch Pumps Market?

Technological advancements are driving innovation in insulin patch pumps, improving their functionality, accuracy, and user experience. The integration of Bluetooth and smartphone connectivity allows patients to monitor their glucose levels and adjust insulin doses remotely, offering greater convenience and control. Some patch pumps are now equipped with CGM systems, enabling real-time glucose monitoring and automatic insulin adjustments, reducing the risk of hypo- or hyperglycemia. Furthermore, advancements in materials science have led to more comfortable and durable patches that adhere securely to the skin, even during physical activity. These technological improvements are making insulin patch pumps more appealing to both patients and healthcare providers, increasing their adoption.

How Do Market Segments Define the Growth of the Insulin Patch Pumps Market?

Types of insulin patch pumps include disposable and reusable models, with disposable pumps gaining popularity due to their convenience and ease of use. End-users of insulin patch pumps include adults and children with type 1 and type 2 diabetes, with the adult population being the largest segment as insulin-dependent diabetes is more prevalent in adults. Distribution channels for insulin patch pumps include hospitals, pharmacies, and online platforms, with hospitals being the primary channel for initial device prescriptions and training. The market is expanding rapidly in regions such as North America and Europe, where diabetes prevalence is high and healthcare infrastructure supports advanced diabetes management solutions.

What Factors Are Driving the Growth in the Insulin Patch Pumps Market?

The growth in the insulin patch pumps market is driven by several factors, including the increasing prevalence of diabetes, advancements in wearable medical technology, and the rising demand for patient-friendly diabetes management solutions. As the global incidence of diabetes continues to rise, particularly in regions such as North America and Europe, the need for effective and convenient insulin delivery methods is growing. Technological innovations, such as the integration of continuous glucose monitoring and smartphone connectivity, are further driving the adoption of insulin patch pumps by offering more precise and flexible insulin management. Additionally, the shift toward personalized healthcare and the increasing preference for discreet, wearable devices are contributing to the growing popularity of insulin patch pumps among patients and healthcare providers.

Select Competitors (Total 42 Featured) -

• Becton
• Cellnovo Limited
• CeQur SA
• Debiotech S.A.
• Dickinson and Company
• Eoflow Co. Ltd
• Insulet Corporation
• Johnson & Johnson
• Unilife Corporation
• Valeritas Holdings Inc

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.